Duxin Sun

机构：Shenyang Institute of Engineering, University of Michigan, Michigan Medicine, Michigan Cancer Research Consortium, U-M Rogel Cancer Center · ORCID：0000-0002-6406-2126

发表论文 465 篇 · 总被引 22296 次 · h-index 71

代表论文

• CCDC 2020870: Experimental Crystal Structure Determination (2026 · Open MIND · 被引 9)
• Discovery and preclinical activity of the menin-KMT2A inhibitor ziftomenib in acute leukemia models (2026 · Blood · 被引 3)
• Machine Learning Model Predicts Clinical Adverse Events of Small Molecule Kinase Inhibitors in Cancer Patients Using On‐/Off‐Target Engagement and Tissue Selectivity (2026 · Clinical Pharmacology & Therapeutics · 被引 1)
• AI and machine learning for predicting in vitro/preclinical drug toxicities and adverse events in clinical patients (2026 · Acta Pharmaceutica Sinica B · 被引 1)
• Dual targeting of PI3Kγ and STING overcomes regulatory B cell- and myeloid cell-driven immune suppression in pancreatic cancer (2026 · Nature Cancer · 被引 1)
• Discovery ofHighly Efficacious CRBN-Based KRAS DegradersTargeting Cancers with KRAS G12D and G12V Mutations (2026 · Journal of Medicinal Chemistry)